Veradermics is trading at $117.14 (+6.32%) in pre-market as growth and biotech stocks rally amid a broad risk-on move following softer CPI data.
- The upward trend appears driven by improved market sentiment and higher U.S. futures rather than fresh company-specific news.
- The stock continues to experience active trading volume following significant volatility and large price swings earlier in July.